Counterfeit SFP modules
Cheap optics cause flaky links on EHR network. Authenticity checks and authorized reseller policy stop further installs.
Component Authenticity
High Risk
Moderate
Low Cost
SA-19 requires developing and implementing anti-counterfeit policy, component authenticity means, and reporting of counterfeit components. Counterfeit network gear, fake medical device parts, and modified software packages threaten confidentiality and availability of ePHI environments.
Control Objective
Ensure components used in ePHI systems are authentic — detect and report counterfeit or modified items through procurement, inspection, and operational checks.
Implementation Guidance
- Publish anti-counterfeit policy for IT and clinical engineering purchases.
- Buy from authorized channels; maintain approved distributor lists.
- Verify serials/holograms/firmware signatures on critical receipts.
- Use vendor authenticity tools where offered.
- Quarantine suspect components; report to vendor/authorities as appropriate.
- Train procurement and dock staff (PE-16) on red flags.
- Extend to software package signing and checksum verification.
- Align with SR-11 component authenticity in supply-chain program.
Real-World Use Cases
How this control shows up in healthcare and HIPAA-covered environments.
Modified USB installer
Unsigned utility found on a vendor USB. SA-19 software authenticity rules reject the media.
Clone infusion pump accessory
Non-OEM part fails verification. Biomed quarantine prevents use on networked pumps.
Best Practices
- Authorized supplier lists.
- Receipt authenticity verification.
- Firmware/signature checks.
- Quarantine and reporting process.
- Train dock/procurement staff.
- Cover hardware and software.
Common Gaps & Violations
- Gray-market purchases for critical path gear.
- No serial verification.
- Ignoring vendor authenticity advisories.
- Unsigned scripts run on interface engines.
- No reporting path for suspects.
Required Documentation
- Component authenticity / anti-counterfeit policy (SA-19)
- Authorized distributor lists
- Inspection checklists
- Quarantine/reporting procedures
- Sample verification records
How to Test & Validate
- Sample critical purchases for channel and authenticity checks.
- Review quarantine log for suspect items.
- Verify staff training for procurement/dock.
- Check software package verification in a deployment.
- Confirm alignment with SR-11 procedures.
Audit Considerations
Counterfeit components are a known healthcare IT problem. Assessors want procurement discipline and inspection evidence for critical ePHI infrastructure.
HIPAA Mapping
How this NIST control supports HIPAA Security Rule expectations.
- 164.312(c) Integrity — counterfeit components can alter or disrupt ePHI processing.
- 164.308(a)(1) Risk Analysis — include counterfeit/supply fraud scenarios.
- 164.310(d) Device and Media Controls — control introduction of hardware into the environment.
- 164.308(b) BA/vendor assurances — acquire from trustworthy sources.
Compliance Tips
- Prefer authorized resellers for firewalls, servers, and clinical networked devices.
- Put authenticity checks on the PE-16 intake form.
- Subscribe to vendor counterfeit bulletins.
Frequently Asked Questions
Is SA-19 duplicated by SR-11?
Often yes in Rev 5 mapping — implement one coherent authenticity program and satisfy both IDs if present in your KB.
Are refurbished devices allowed?
Only via approved channels with authenticity and sanitization guarantees documented.
Does this include cloud regions?
Focus on components you acquire; cloud authenticity is largely provider-side with shared responsibility for images you import.
References & Resources
- NIST SP 800-53 Rev. 5 — SA-19
- Related controls: SR-11, PE-16, SR-4, SI-7, SA-12
Related Guidelines
Related controls that commonly accompany SA-19.
Need Help Implementing SA-19?
Our auditors map NIST SP 800-53 controls to your HIPAA Security Rule program — policies, technical evidence, and audit readiness.